Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial - The Lancet Oncology
Vinorelbine 50mg Injection Navelbine | M Care Exports | Exporter